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ABSTRACT
Objective: This study aimed to observe the effect of the 70% ethanol extract of Orthosiphonis stamineus Benth leaves on the pharmacokinetic 
parameters of furosemide in white male rats.
Methods: 18 Sprague–Dawley male rats were divided into three groups: The normal control group was given only 1% carboxymethyl cellulose, 
the furosemide group was given 7.2 mg/200 g body weight (BW) suspension of furosemide, and the combination group was given 700 mg/kg BW 
suspension of the 70% ethanolic extract of O. stamineus Benth leaves for 4 days followed by a 7.2 mg/200 g BW suspension of furosemide. On the 
4th day of treatment, we performed orbital sinus blood sampling on the eyes of the rats and analyzed the levels of furosemide in plasma using high-
performance liquid chromatography.
Results: Therefore, the results showed that the administration of the 70% ethanol extract of O. stamineus Benth leaves improves the pharmacokinetic 
parameters of furosemide on Cpmax and the area under the curve (p<0.05).
Conclusion: This study concludes that the 70% ethanol extract of O. stamineus Benth leaves improves the pharmacokinetic parameters of furosemide 
in white male rats.
Keywords: Cat’s whiskers leaves, Furosemide, Orthosiphonis stamineus Benth, Pharmacokinetic, 70% ethanolic extract.
INTRODUCTION
Furosemide is an anthranilic acid derivative drug included in powerful 
diuretics. Based on the research conducted by Bragatto et al. [1], a 
single dose of 40 mg furosemide given orally produced significant 
results in increasing the volume of urine and had a pharmacokinetics 
ratio interval of Cmax (93.63-121.92%), area under the curve (AUC0−t) 
(96.80-115.72%), and AUC0−∞ (98.45-117.43%). Another study 
mentions that the administration of furosemide with a dose of 
8 mg/200 g body weight (BW) produced AUC0−∞ 13.52±52.29 µg/mL 
hr with Cmax 22:34±4:39 µg/mL [2]. Indonesian herbal medicine has 
been used for hundreds of years, long before the advent of modern 
medicine that involves a diagnostic laboratory and chemicals [3]. The 
results of basic medical research in 2010 showed that about 59.12% 
of Indonesia’s population consumes herbs [4]. Cat’s whiskers is a 
medicinal plant that has been empirically shown to act as a diuretic. 
Tensigard® is a phytopharmacological preparation containing extracts 
of cat’s whiskers leaves combined with celery extract and is used as an 
antihypertensive due to its diuretic properties.
The use of cat’s whiskers leaf extract and furosemide at the same 
time can cause a pharmacokinetic interaction that can increase or 
decrease furosemide levels in plasma. As a result, drug toxicity and 
drug effectiveness may also increase or decrease [5]. The diuretic 
effect of cat’s whiskers leaf extract is demonstrated by the inhibition 
of adenosine receptor A1, which will inhibit sodium reabsorption in the 
proximal tubules [6], and the diuretic mechanism of furosemide diuretic 
inhibits reabsorption of electrolytes Na+/K+/2Cl− in the ascending limb 
of the loop of Henle in the thick epithelium section. The diuretic effect of 
cat’s whiskers leaf extract and furosemide was similarly with inhibiting 
sodium reabsorption in the nephron [7]. The changes in the levels of 
the combined drugs will affect the pharmacokinetic parameters of 
furosemide, and this study observes the influence of cat’s whiskers 
leaf extract on the pharmacokinetic parameters of furosemide in white 
male rats using blood plasma samples.
MATERIALS AND METHODS
Materials
The material sample used in this study was the 70% ethanol extract 
of cat’s whiskers leaf (Orthosiphonis stamineus Benth.) obtained from 
the Research Center for Spices and Medicinal Plants. Determination 
of cat’s whiskers leaf was conducted by the Indonesian Institute of 
Sciences, Bogor Botanical Gardens. Animals used in this study were 
30 Sprague–Dawley rats: 12 samples for the optimization of timing 
and 18 for the actual test. The rats were male, approximately 3 months 
old and approximately 200 g in weight, and were obtained from the 
Institut Pertanian Bogor. The chemicals used include furosemide 
(Kimia Farma), furosemide standard (BPFI), propranolol HCl (BPFI), 
carboxymethyl cellulose (CMC) (Brataco Chemical), methanol (high-
performance liquid chromatography [HPLC] grade, Merck), phosphoric 
acid (85%) (Merck), ethyl acetate (Merck), human blood plasma from 
Palang Merah Indonesia, Aqua Bidest distilled water, food standards 
for test animals, anhydride acetic acid, Mayer’s reagent, Dragendorff’s 
reagent, Bouchard’s reagent, Molisch’s reagent, iron (III) chloride 
reactant solution, hydrochloric acid, zinc powder, and magnesium 
powder.
Instruments
The instruments used in this study were stomach probes, syringes 
(Terumo), animal scales, an analytical balance (Ohaus), microhematocrit 
capillary tubes, a set of HPLC LC-10AD VP tools (Shimadzu) consisting 
of a pump, an injector, C18 column of RP-18e (Waters, Sunfire TM 5 μm; 
250 × 4.6 mm), detector SPD-20A ultraviolet-visible (UV-Vis), DGU-12A 
degasser, SCL-10A VP controller, and data processing on a computer, 
UV-1601 (Shimadzu), pH meter (Eutech pH 700), vortex (Maxi 
Mix II), microcentrifugator (Spectrafuge 16 M), refrigerator (Lab Tech), 
centrifugator (Digisystem), evaporator (Caliper), microtube, centrifuge 
tubes, 0.45 µm membrane filter, micropipette and pipette (blue tip/
yellow tip), reaction tube, test tube rack, vaporizer cup, beaker (Pyrex), 
spatula, stir bar, measuring glass (Pyrex), and flask (Pyrex).
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Test material preparation
Preparation of the test material included producing CMC solution of 
1%, producing the furosemide suspension, producing the 70% ethanol 
extract suspension of cat’s whiskers leaves extract, producing a mobile 
phase of methanol–water (50:50) that adjusted to phosphoric acid 
(85%) at pH of 3.0, producing furosemide solution for optimization, 
producing propranolol HCl solution for internal standard solution, and 
producing furosemide solutions for calibration curve.
Qualitative phytochemical screening of 70% ethanol extract from 
cat’s whiskers leaves
Qualitative phytochemical screening of the 70% ethanol extract of cat’s 
whiskers leaves consisted of organoleptic, alkaloid, phenol, flavonoids, 
and terpenes identification. Organoleptic evaluation was conducted by 
observing the form, color, and odor of the extract [8]. Alkaloids were 
identified with Dragendorff’s, Mayer’s, and Bouchard’s reagent solutions. 
Alkaloid was indicated by the orange precipitate through Dragendorff’s 
reagent, the yellow precipitate through Mayer’s reagent, and the reddish-
brown sediment through Bouchard’s reagent [9]. Phenol was identified by 
adding 3-4 drops of iron (III) chloride reactant solution. Phenol is shown 
in the formation of a bluish-black color [10]. Flavonoids were identified 
by the Shinoda test [9]. Identification of terpene was accomplished by 
the addition of ether, which was then allowed to evaporate, then added 2 
drops of acetic acid anhydride, and 1 drop of sulfuric acid [9].
Test animal preparation
Before treatment, rats were acclimatized for 2 weeks in an animal 
cage at the Pharmacology-Toxicology Laboratory of the Faculty of 
Pharmacy, University of Indonesia. The test used 18 male rats with six 
rats in each group. In the experiment, rats were randomly divided into 
three groups: The normal control group, the furosemide group, and 
the extract furosemide combination group. After acclimatization, the 
rats were given an appropriate treatment according to the group, with 
the time of treatment tailored to the timing of optimization results. 
A dose of 70% of ethanol extract from cat’s whiskers leaves is the 
most widely used dose for diuretic purposes, which is about 700 mg/
kg. The furosemide dose was an empirical dose most commonly 
used in society to treat diuretic problems and is measured at about 
40 mg/human. The furosemide dose for rats was approximately 40 × 
0.018 × 10=7.2 mg/200 g rat BW.
Dosage and time optimization
12 of the test animals were divided into four groups of three test animals. 
Group 1 was the normal group, Group 2 was given the suspension of 
furosemide at a dose of 7.2 mg/200 g BW orally, Group 3 received the 
suspension of 70% ethanol extract of cat’s whiskers leaves at a dose 
of 700 mg/kg given orally for 4 days followed by the suspension of 
furosemide at a dose of 7.2 mg/200 g BW, and Group 4 was given the 
suspension of 70% ethanol extract of cat’s whiskers leaves at a dose of 
700 mg/kg orally for 7 days followed by the suspension of furosemide 
at a dose of 7.2 mg/200 g BW (Table 1). Before administering the 
furosemide, we gave the rats warm distilled water (25 ml/kg) as a 
loading dose. The parameters measured were the increases in the 
average urine volume of each test group.
Examination of furosemide levels in the blood
Measurements of the furosemide content of the 70% cat’s whiskers 
ethanol extract and the furosemide levels in blood plasma were 
performed using HPLC. The study began by fasted the test animals for 
12 hrs before administering the extract and furosemide on the last day 
of treatment. This treatment aims to condition the animal test and to 
minimize drug interactions with other substances potentially present 
in the rats.
Blood was drawn from the orbital sinus of the rat’s eye after 
administration of the furosemide suspension. Blood collected in a 
microtube, and already given heparin was centrifuged for 10 minutes at 
3500 rpm; then, the supernatant was transferred to a new microtube. 
Put 250 mL plasma, add 50 mL of internal standard, and then extracted. 
The solution from the extraction (20 mL) was injected to HPLC by 
chromatographic conditions chosen using C18 column (250 × 4.6 mm, 
5 µm), UV-Vis detector [11]. Measurements were taken at 0, 0.5, 1, 1.5, 
2, 2.5, 3, 4, 8, and 10 hrs after administration of the furosemide.
Optimization of condition analysis
Wavelength analysis involved the use of a UV-Vis spectrophotometer at 
a concentration of 10 µg/mL. Optimization of the mobile phase ratio 
included three comparisons: Methanol–water (50:50 v/v) pH 3.0, 
methanol–water (55:45 v/v) pH 3.0, and methanol–water (60:40 v/v) 
pH 3.0, using solutions containing 10 mg/mL of furosemide and 100 mg/
mL of propranolol HCl. The pH modification of the mobile phase was at 
pH 2.8, pH 3.0, and pH 3.2. Further modification of the flow rate was 0.8, 
1.0, and 1.2 mL/min. Each optimization was compared to the retention 
time (tR), the peak area (A), tailing factor (Tf), the value of the number of 
theoretical plates (N), HETP, and the resolution (R). The coefficient of 
variation (CV) was obtained after 6 repetitions of the test.
Optimization of extraction method
250 µL of plasma containing 10 µg/mL of furosemide in a centrifugation 
tube added 50 µL containing 50 µg/mL propranolol HCl, and then, 
vortex a 10 seconds. The mixture was added ethyl acetate as much as 
10 times of the mixture, and then, vortex for 1 minute. The mixture 
was centrifuged for 20 minutes at 3000 rpm. The supernatant was 
taken and evaporated with nitrogen gas for 15 minutes at 60°C. The 
residue was dissolved in 200 mL of the mobile phase, and as much as, 
20 mL of the solution was injected into the HPLC instrument on the 
condition of the selected analysis. Optimization time of vortex was 
30 seconds, 1 minute, and 1.5 minutes. Furthermore, optimization time 
of centrifugation was 10 minutes and 20 minutes. Each optimization 
was performed by observing the maximum peak of the analysis.
Validation method
Producing calibration curve and linearity test
A calibration curve was created with plasma comprising one blank 
sample (plasma without raw), a zero sample (plasma raw), and 7 
concentration gradients of calibration curve: 1, 5, 10, 15, 20, 30, and 
40 µg/mL. Each concentration for the calibration curve was added 
raw in as much as 50 µL from 50 ppm and extracted as in the sample. 
Linearity was determined by calculating the correlation coefficient 
of the linear regression of the calibration curve. In addition, the 
calculated value % difference for each produced calibration curve 
with the requirements should not be more than ±15%, except for 
the lowest quantitation limit determination (LLOQ) solution, which 
should not be more than ±20%.
LLOQ
We prepared a standard furosemide solution in plasma at LLOQ 
concentration (based on the calculation of the calibration curve 
series) and then added internal standard and prepared as in the 
sample. The injection was repeated 5 times. From the measurement 
data, we then calculated the value % difference and CV with the 
requirements of not more than 20%. If the solution at the tested 
concentration met the requirements, then it was retested by half 
of the initial concentration. This process was performed until the 
lowest concentration was obtained that still met the requirements, 
otherwise known as LLOQ.
Table 1: Group division and animal testing
Group Treatment
Control Provision of CMC 1%
Furosemide Provision of furosemide suspension 
7.2 mg/200 g BW
Combination Provision of 70% cat’s whiskers ethanol 
extract 700 mg/kg BW+furosemide 
suspension 7.2 mg/200 g BW
CMC: Carboxymethyl cellulose, BW: Body weight
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Accuracy and precision
We prepared a plasma containing the solution at LLOQ concentrations 
and at low (QCL), moderate (QCM), and high (QCH) concentrations.
• QCL=3 × concentration of LLOQ (1 µg/mL)=3 µg/mL,
• QCM=50% in the calibration curve concentration range=20 mg/mL,
• QCH=75% × upper limit of quantification (40 µg/mL)=30 µg/mL.
Each concentration received the standard preparation of 50 mL. 
Tests were repeated 5 times for each concentration intraday (within 
run) and interday (between run) for at least 2 different days with a 
minimum of three test iterations. We then calculated the % difference 
as the parameter of accuracy and % CV as a precision parameter. The % 
difference and CV value should not exceed ±20% of the sample LLOQ 
and should not exceed ±15% for all quality control samples.
Pharmacokinetic parameters of furosemide in blood
Pharmacokinetic parameters calculated were the absorption rate 
constant (Ka), the peak time (tmax), the peak plasma concentration 
(Cpmax), the elimination rate constant (Ke), the half-life (t1/2), the volume 
of distribution (Vd), the clearance (Cl), and the AUC. Each of these 
pharmacokinetic parameters was analyzed using SPSS to determine the 
normality as well as the significance of the data.
RESULTS AND DISCUSSIONS
Phytochemical screening of the 70% ethanol extract of cat’s 
whiskers leaves
Organoleptic evaluation is useful for knowing the characteristics of 
cat’s whiskers leaf extract. Observations showed that the 70% ethanol 
extract of cat’s whiskers leaf was in the form of a slightly thick liquid, 
had a distinctive smell, and was a blackish-green color. The yield 
produced in the simplex process of the cat’s whiskers plant was 7.43%. 
Furthermore, a phytochemical screening process was conducted to 
determine the class of bioactive compounds contained in the extract. 
Phytochemical screening conducted at the Research Institute for Spices 
and Medicinal Plants showed positive results for alkaloids, phenols, 
flavonoids, and terpenes. Phytochemical screening was also performed 
at the Phytochemistry Laboratory of the Faculty of Pharmacy, UI, and 
the results are shown in Table 2.
Time optimization of the 70% ethanol extract of cat’s whiskers 
leaves
Based on the average, we can see that the volume mean of urine was the 
most in the group given the 70% ethanol extract of cat’s whiskers leaves 
for 4 days followed by the furosemide dose on day 4. The first urine 
volume measurement was 11.166 mL; at the 2nd hr, the volume rose 
to 15.833 mL; at the 3rd hr, it measured at 17.50 mL; and the amount 
remained stable from 4 to 6 hrs (at a volume of 18.50 mL). Time for 
4 days of the extract was used as the actual test. Optimization results for 
the average volume of rat urine for 6 hrs are shown in Table 3.
Optimization of condition analysis
The optimum wavelength selected for furosemide analysis was 236 nm. 
This wavelength was chosen because it is the greatest absorption of 
furosemide. In mobile phase ratio selection, methanol–water (60:40 v/v) 
pH 3.0 was used as the first mixture of mobile phase. In this mobile 
phase composition, furosemide and propranolol HCl, respectively, have 
a retention time of 5.472 and 2.900 minutes; theoretical plates (N) of 
1851.523 and 1258.122; HETP of 0.0135 and 0.0199; tailing factor (Tf) 
of 1.641 and 0.880; and a resolution of 6.154. Then, that mobile phase 
is modified to methanol–water (55:45 v/v) pH 3.0 and methanol–water 
(50:50 v/v) pH 3.0. The composition of methanol–water (55:45 v/v), 
furosemide and propranolol HCl, respectively, had a retention time 
of 7.405 and 3.043 minutes; theoretical plates (N) of 2514.007 and 
1515.980; HETP of 0.0099 and 0.0165; tailing factor (Tf) of 1.695 and 
1.750; and resolution of 9.658. The composition of methanol–water 
(50:50 v/v), furosemide and propranolol HCl, respectively, had a 
retention time of 10.677 and 3.340 minutes; theoretical plates (N) of 
4002.193 and 2926.168; HETP of 0.0062 and 0.0085; tailing factors (Tf) 
of 1.689 and 1.874; and resolution of 15.914.
The pH optimization of mobile phase, methanol–water (50:50 v/v) 
pH 2.5 showed that retention time of furosemide and propranolol HCl 
was 9.291 and 4.040 minutes, respectively, whereas the composition of 
methanol–water (50:50 v/v) pH 3.5 retention time of furosemide and 
propranolol HCl was 13.257 and 3.451 minutes, respectively. The flow 
rate was used as an initial condition, and it was 1.0 mL/minute. The 
flow rate of 1.0 mL/minute obtained retention time of furosemide and 
propranolol HCl, respectively, was 10.577 and 3.335 minutes. The flow 
rate of 1.2 mL/minute retention time in furosemide and propranolol 
HCl, respectively, was 9.038 and 2.844 minutes, whereas the flow rate 
of 0.8 mL/minute had a retention time in furosemide and propranolol 
HCl, respectively, of 13.449 and 4.713 minutes and resolution of 14.508 
(≥1.5); Tf=1.527 (≤2); and N=3726.252 (≥2.000). This study showed 
that % CV was <2.0%. The results obtained by each system suitability 
test performed yielded a CV value of <2.0%. Time analysis of each 
injection was 15 minutes.
Optimization of extraction method
Data optimization with a vortex agitation time of 30 seconds resulted 
in a furosemide area of 304.907; vortex agitation for 1 minute resulted 
in a furosemide area of 318.954; and vortex agitation for 1.5 minutes 
resulted in a furosemide area of 285.781. Playback of time optimization 
data by centrifugation, namely, the screening of 10 minutes, showed a 
Table 2: Results of phytochemical screening of the 70% ethanol extract of cat’s whiskers leaves
Identification Results Information
Alkaloids Orange precipitate (Dragendorff’s reagent), yellow (Mayer’s reagent), and 
reddish-brown (Bouchard’s reagent)
Positive, contains alkaloids
Phenol Bluish-black color Positive, contains phenol
Flavonoids Red color formed in Shinoda reaction Positive, contains flavonoids
Terpene Color change occurred Positive, contains terpenes
Table 3: Average volume of rat urine for 6 hrs in a preliminary test
P Treatment group The average volume of urine at hours of mL±SD
1 2 3 4 5 6
Control 2.2±1.0 5.7±2.5 6.3±2.1 6.8±1.6 6.8±1.6 6.8±1.6
Furosemide 8.0±1.0 15.7±1.6 15.7±1,6 15.7±1.6 15.7±1.6 15.7±1.6
Combination for 4 days 11.2±3.2 15.8±2.1 17.5±1.3 18.5±1.0 18.5±1.0 18.5±1.0
Combination for 7 days 9.8±1.4 13.2±1.3 15.5±1.3 16.0±0.5 16.0±0.5 16.2±0.8
Information: Control=With CMC 1%; furosemide=Furosemide of 7.2 mg/200 g BW, combination=Extract of Cat’s whiskers leaf of 700 mg/kg+furosemide 
7.2 mg/200 g BW. CMC: Carboxymethyl cellulose, BW: Body weight, SD: Standard deviation
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furosemide area of 326.004, while the playback for 20 minutes showed 
a furosemide area of 337.592. This study showed that % CV was <2.0%. 
The results obtained by each system suitability test performed yielded 
a CV value <2.0%.
Validation of partial analysis methods
Producing calibration curve and linearity test
The calibration curve consists of a plasma blanket (plasma without 
analyte and internal standard), zero sample (plasma with internal 
standard), and non-zero plasma (plasma with analyte and internal 
standard) of 7 concentrations: 1.0, 5.0, 10.0, 15.0, 20.0, 30.0, and 
40.0 µg/mL. The calibration curve produces a linear regression equation 
in the form y=0.1737x+0.0109 with r2=0.999; where x is the concentration 
of furosemide (mg/mL) and y is the PAR between furosemide and 
propranolol HCl raw. Based on the data, the CV value obtained was no 
more than >±15% for all concentrations, including the LLOQ.
LLOQ
In bioanalytics, LLOQ values should cover at least 1/20 of the maximum 
concentration (C max) of analytes in plasma. In this study, concentrations 
of 1.0 ug/mL were used to limit LLOQ temporary, and this concentration 
is repeated as many as five replicas. The value % difference and CV 
at concentrations of 1.0 mg/mL still met the criteria for accuracy and 
precision of <±20%. We then diluted half of the concentration of 0.5 mg/mL 
and made five identical samples. The value % difference and CV generated 
at a concentration of 0.5 mg/mL did not meet the criteria for accuracy and 
precision, so the LLOQ was used as a concentration limit of 1.0 mg/mL.
Accuracy and precision
Accuracy and precision were tested by intra- and inter-days. 
The intraday accuracy measurement values obtained for LLOQ 
concentration % difference ranged from −13.25% to −19.27%, and 
for the QC concentration, it ranged from −1.50% to −19.27%. For the 
intraday precision measurements, we obtained a CV value of <4.75% for 
LLOQ and QC concentrations. For the interday measurement accuracy 
for the LLOQ concentration, we obtained a range of % difference from 
−11.66% to +19.27%, and for the QC concentration, the range % 
difference was−0.68% to +14.96%. The measurement of the interday 
precision was a CV value of <5.79%. The value % difference and CV for 
both intraday and interday met accuracy and precision standards.
Pharmacokinetic analysis of furosemide in rat blood plasma
The rat plasma obtained was analyzed using HPLC with previously 
validated analysis conditions. The plasma furosemide concentration 
obtained in the administration of the single and combined furosemide 
with the 70% ethanol extract of cat’s whiskers was calculated by 
pharmacokinetic parameters. The mean of pharmacokinetic parameter 
data obtained can be seen in Table 4.
Description
The time optimization of a comparative analysis of selected mobile 
phases is a mobile phase composition of methanol–water mixture 
(50:50 v/v) that adjusted by phosphoric acid to a pH of 3.0. The selection 
was based on the retention time and resolution between the analyte 
and internal standard. In this mobile phase composition, separation 
and retention time of internal standard was a little longer than the 
mobile phase of methanol–water (55:45) and methanol–water (60:40). 
In the mobile phase of methanol–water (50:50 v/v) pH 3.0, the peak of 
the analyte on the chromatogram was more pointed and had a better 
resolution than pH 2.5 and pH 3.5. The flow rate used for analysis was 
0.8 mL/minute with resolution was 14.508 (≥1.5); Tf=1.527 (≤2); and 
N=3726.252 (≥2.000), that qualifies the method of analysis. At a flow 
rate of 1.0 mL/min and 1.2 mL/min, the retention time of propranolol 
HCl (internal standard) allowed peak plasma impurities that would 
interfere with the peak of the analyte.
The extraction method used was a liquid–liquid extraction method. 
This method was chosen because it results in fewer impurities than 
the protein precipitation method. Ether or ethyl acetate can be used for 
drug extraction from plasma, but on this study, ethyl acetate offers the 
cleanest chromatogram compared to ether use. The time optimization 
of agitation with the vortex showed that the longer the shaking time, 
the more analytes and raw were extracted, so a greater response peak 
area was produced; however, if shaken for too long, fewer analytes and 
raw were extracted, so the response peak area produced was much 
smaller. Therefore, 1 minute shuffling time was chosen, because at 
that time, it provides the broadest peak response. Time optimization 
by centrifugation showed that the longer centrifugation would result 
in better separation so that the generated response peak area would 
be greater, 20 minutes for centrifugation was chosen. In the method 
validation, calibration curve measurements, accuracy, and precision 
values were obtained as CV and % difference in accordance with the 
requirements for all concentrations, including LLOQ.
The results of pharmacokinetic analysis of furosemide in the blood 
plasma of white rats showed that administration of a combination of 
70% ethanol extract of cat’s whiskers leaves and furosemide did not 
result in a significant decrease (p>0.05) in the rate of absorption but 
also did not significantly increase the rate of elimination. An increase in 
the rate of elimination means more drugs were being released from the 
body. This corresponds to the diuretic mechanism of increasing urine 
volume. The time of plasma concentration peak did not change, while 
the half-life decreased. Rises in value elimination rate cause a decline in 
how long the drug is present in the body [12].
Decreased clearance did not differ significantly. Clearance value 
is directly proportional to the volume of distribution and the 
elimination rate [12]. The decline in value is due to the volume of 
distribution clearance, which also decreased significantly while the 
elimination rate increased. The volume of distribution shows the 
amount of drug distribution in the body. The volume of distribution 
is also related to the amount of drug in the plasma. If the volume of 
distribution increases, the drug concentration in the plasma will be 
small and otherwise [12]. The peak plasma concentration increased 
significantly (p<0.05), as well as the AUC. This increase indicates 
an increase in the plasma concentration of therapeutic furosemide. 
Increasing concentrations of furosemide are still relatively safe 
because it does not reach a toxic level. Under the U.S. Food and Drug 
Administration and the World Health Organization guidelines on 
bioequivalence, furosemide plasma concentrations reach toxicity in 
the interval of 25-30 mg/mL [13].
Based on the results of the phytochemical screening, cat’s whiskers 
leaves contain flavonoids, alkaloids, terpenes, and phenols. The increase 
in pharmacokinetic parameters in male rats caused by the presence of 
methoxy flavonoids that can induce diuretic through the activity of the 
adenosine A1 receptor antagonist that is involved in the regulation of 
the flow rate of urine and the excretion of sodium [14,15]. Inhibition 
Table 4: The mean of pharmacokinetic parameters in the 




Ka −1 hr 0.96±0.08 0.88±0.07
tmax hr 2.5±0 2.5±0
Cpmax ug mL−1 13.63±2.01* 18.16±0.81*
To −1 hr 0.70±0.22 0.78±0.04
t½ hr 3.03±0.80 2.54±0.28
Vd mL 537.90±81.71* 397.06±17.22*
Cl hrs mL−1 364.64±100.28 308.51±13.23
AUC0−t ug mL−1 hr 46.92±4.91* 62.86±3.99*
AUCt−∞ ug mL−1 hr 12.42±1.22 14.37±2.65
AUC0−∞ ug mL−1 hr 59.34±4.27* 77.23±6.43*
*Indicates significance value <0.05, that means on the two groups have 
significantly different values. AUC: Area under the curve, SD: Standard deviation
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of these receptors would inhibit sodium and water reabsorption in the 
proximal tubules [6].
Administration together between furosemide, which is a potent 
diuretic, with 70% ethanol extract of cat’s whiskers leaves can cause 
interactions that lead to the inhibition of sodium reabsorption in the 
nephron. Furosemide and flavonoids found in cat’s whiskers leaves 
have similar diuretic properties. Furosemide is a diuretic that inhibits 
the reabsorption of electrolytes Na+/K+/2Cl− in the ascending limb of 
the loop of Henle in the thick epithelial part, and flavonoids found in the 
cat’s whiskers plant can inhibit the reabsorption of sodium and water 
in the proximal tubules through inhibition of adenosine receptor A1. The 
diuretic effect of cat’s whiskers leaves also suspected to be due to the 
methylripariochromene compound A (MRC-A). MRC-A diuretic effect is 
shown by an increase in the volume of urine and excretion of Na+, K+, 
and Cl−.
CONCLUSION
Based on these research results, this study concludes that the joint 
administration of 70% ethanol extract of cat’s whiskers leaves 
(O. stamineus Benth) and furosemide can improve the pharmacokinetic 
parameters of furosemide in white male rats, results that were indicated 
by significant increases (p<0.05) in peak plasma concentration (Cpmax) 
and AUC.
The authors also recommend performing the further studies on 
the toxicity of the concurrent use of 70% ethanol extract of the cat’s 
whiskers plant with furosemide.
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